As of 2026-06-25, the Intrinsic Value of Timber Pharmaceuticals Inc (TMBR) is -21.76 USD. This TMBR valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.34 USD, the upside of Timber Pharmaceuticals Inc is -6,452.55%.
Based on its market price of 0.34 USD and our intrinsic valuation, Timber Pharmaceuticals Inc (TMBR) is overvalued by 6,452.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -21.76 - -21.76 | -21.76 | -6,452.55% |
| DDM - Stable | (38.64) - (109.31) | (73.98) | -21692.5% |
| DDM - Multi | (40.89) - (90.19) | (56.30) | -16532.0% |
| Market Cap (mil) | 1.18 |
| Beta | -0.55 |
| Outstanding shares (mil) | 3.43 |
| Enterprise Value (mil) | -1.34 |
| Market risk premium | 5.00% |
| Cost of Equity | 9.73% |
| Cost of Debt | 5.00% |
| WACC | 7.37% |